- Vienna 2018
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: G.Sauder GERMANY
Back to previous
Evaluation of safeness and efficacy of a new add -on IOL.
Prospective , non-randomized, interventional clinical trial
10 patients underwent routine cataract surgery with endocapsular IOL implantation and simultaneous implantation of an add-on IOL, (1stQ, Germany). 5 patients received a multifocal the other 5 a toric add-on IOL. The hydrophylic acrylic IOL is especially designed for sulcus implantation with an rectangular optic design and 4 rectangular haptics. The surgeries were performed under topical anesthesia. By one experienced surgeon.
After a follow up of 3 month, no patient showed signs of inflammation or iris pigment dispersion. IOD was 14.6 ±2.0 mmHg . visual acuity was 0.82 ±0.12. Ultrasound biomicroscopy showed a stable distance of 1.0 1.1 mm between both IOLs. Gonioscopy revealed no significant increase of pigmentation
In this preliminary study with 10 patients the add-on IOL (1stQ, Mannheim, Germany) proved to be a save and predictable tool in refractive cataract surgery